abortion pill

Read the transcript from Wednesday's hearing before Judge Matthew Kacsmaryk in a federal case that could decide the future of access to a major abortion pill.

A new bill in the California Legislature would give legal protections to doctors who mail abortion pills to patients in other states.

If the case succeeds, it could have sweeping repercussions — for abortion providers and patients across the nation, as well as for the FDA's drug-approval process.

California Gov. Gavin Newsom said that the state would halt business with Walgreens after the pharmacy giant agreed to stop distributing mifepristone in some red states amid legal pressure.

The drugstore chain’s announcement that access to mifepristone may not expand as broadly as federal regulators intended when they finalized a rule change allowing more pharmacies to provide the pill. Here’s a closer look at the issue.

The suit comes as a federal judge in another case is considering whether to overturn FDA approval of the same drug, mifepristone.

The state sent an email to all state medical providers about abortion medication and the criminal penalties surrounding it.

In the wake of an FDA decision that allows pharmacies to stock the medication, the Florida agency warned providers that “criminal penalties” could result over violations.

Changes by the FDA mean patients won't have to schedule in-person exams to get a prescription. That opens the door for more pharmacies to provide the medication. But not everyone will have access.

The FDA finalized a rule change that broadens availability of abortion pills to many more pharmacies, including large chains and mail-order companies.